Global Insulin Glargine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Insulin Glargine market size was valued at USD 6902.2 million in 2023 and is forecast to a readjusted size of USD 8978.2 million by 2030 with a CAGR of 3.8% during review period.

nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).

Global Insulin Glargine key players include Sanofi-Aventis, Ganlee, etc. Global top two manufacturers hold a share nearly 50%.

USA is the largest market, with a share over 60%, followed by China, and Europe, both have a share about 35 percent.

In terms of product, Pre-filled Syringe is the largest segment, with a share about 75%. And in terms of application, the largest application is Treat type2 diabetes, followed by Treat type1 diabetes.

The Global Info Research report includes an overview of the development of the Insulin Glargine industry chain, the market status of Treat Type2 Diabetes (Single Dose Vial, Pre-filled Syringe), Treat Type1 Diabetes (Single Dose Vial, Pre-filled Syringe), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Insulin Glargine.

Regionally, the report analyzes the Insulin Glargine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Insulin Glargine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Insulin Glargine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Insulin Glargine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M mL), revenue generated, and market share of different by Type (e.g., Single Dose Vial, Pre-filled Syringe).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Insulin Glargine market.

Regional Analysis: The report involves examining the Insulin Glargine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Insulin Glargine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Insulin Glargine:
Company Analysis: Report covers individual Insulin Glargine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Insulin Glargine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Treat Type2 Diabetes, Treat Type1 Diabetes).

Technology Analysis: Report covers specific technologies relevant to Insulin Glargine. It assesses the current state, advancements, and potential future developments in Insulin Glargine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Insulin Glargine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Insulin Glargine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Single Dose Vial
    Pre-filled Syringe

Market segment by Application
    Treat Type2 Diabetes
    Treat Type1 Diabetes

Major players covered
    Sanofi-Aventis
    Ganlee
    Biocon

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Insulin Glargine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Insulin Glargine, with price, sales, revenue and global market share of Insulin Glargine from 2019 to 2024.
Chapter 3, the Insulin Glargine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin Glargine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Insulin Glargine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Insulin Glargine.
Chapter 14 and 15, to describe Insulin Glargine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Insulin Glargine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Insulin Glargine Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Single Dose Vial
        1.3.3 Pre-filled Syringe
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Insulin Glargine Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Treat Type2 Diabetes
        1.4.3 Treat Type1 Diabetes
    1.5 Global Insulin Glargine Market Size & Forecast
        1.5.1 Global Insulin Glargine Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Insulin Glargine Sales Quantity (2019-2030)
        1.5.3 Global Insulin Glargine Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Sanofi-Aventis
        2.1.1 Sanofi-Aventis Details
        2.1.2 Sanofi-Aventis Major Business
        2.1.3 Sanofi-Aventis Insulin Glargine Product and Services
        2.1.4 Sanofi-Aventis Insulin Glargine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Sanofi-Aventis Recent Developments/Updates
    2.2 Ganlee
        2.2.1 Ganlee Details
        2.2.2 Ganlee Major Business
        2.2.3 Ganlee Insulin Glargine Product and Services
        2.2.4 Ganlee Insulin Glargine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Ganlee Recent Developments/Updates
    2.3 Biocon
        2.3.1 Biocon Details
        2.3.2 Biocon Major Business
        2.3.3 Biocon Insulin Glargine Product and Services
        2.3.4 Biocon Insulin Glargine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Biocon Recent Developments/Updates

3 Competitive Environment: Insulin Glargine by Manufacturer
    3.1 Global Insulin Glargine Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Insulin Glargine Revenue by Manufacturer (2019-2024)
    3.3 Global Insulin Glargine Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Insulin Glargine by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Insulin Glargine Manufacturer Market Share in 2023
        3.4.2 Top 6 Insulin Glargine Manufacturer Market Share in 2023
    3.5 Insulin Glargine Market: Overall Company Footprint Analysis
        3.5.1 Insulin Glargine Market: Region Footprint
        3.5.2 Insulin Glargine Market: Company Product Type Footprint
        3.5.3 Insulin Glargine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Insulin Glargine Market Size by Region
        4.1.1 Global Insulin Glargine Sales Quantity by Region (2019-2030)
        4.1.2 Global Insulin Glargine Consumption Value by Region (2019-2030)
        4.1.3 Global Insulin Glargine Average Price by Region (2019-2030)
    4.2 North America Insulin Glargine Consumption Value (2019-2030)
    4.3 Europe Insulin Glargine Consumption Value (2019-2030)
    4.4 Asia-Pacific Insulin Glargine Consumption Value (2019-2030)
    4.5 South America Insulin Glargine Consumption Value (2019-2030)
    4.6 Middle East and Africa Insulin Glargine Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Insulin Glargine Sales Quantity by Type (2019-2030)
    5.2 Global Insulin Glargine Consumption Value by Type (2019-2030)
    5.3 Global Insulin Glargine Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Insulin Glargine Sales Quantity by Application (2019-2030)
    6.2 Global Insulin Glargine Consumption Value by Application (2019-2030)
    6.3 Global Insulin Glargine Average Price by Application (2019-2030)

7 North America
    7.1 North America Insulin Glargine Sales Quantity by Type (2019-2030)
    7.2 North America Insulin Glargine Sales Quantity by Application (2019-2030)
    7.3 North America Insulin Glargine Market Size by Country
        7.3.1 North America Insulin Glargine Sales Quantity by Country (2019-2030)
        7.3.2 North America Insulin Glargine Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Insulin Glargine Sales Quantity by Type (2019-2030)
    8.2 Europe Insulin Glargine Sales Quantity by Application (2019-2030)
    8.3 Europe Insulin Glargine Market Size by Country
        8.3.1 Europe Insulin Glargine Sales Quantity by Country (2019-2030)
        8.3.2 Europe Insulin Glargine Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Insulin Glargine Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Insulin Glargine Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Insulin Glargine Market Size by Region
        9.3.1 Asia-Pacific Insulin Glargine Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Insulin Glargine Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Insulin Glargine Sales Quantity by Type (2019-2030)
    10.2 South America Insulin Glargine Sales Quantity by Application (2019-2030)
    10.3 South America Insulin Glargine Market Size by Country
        10.3.1 South America Insulin Glargine Sales Quantity by Country (2019-2030)
        10.3.2 South America Insulin Glargine Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Insulin Glargine Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Insulin Glargine Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Insulin Glargine Market Size by Country
        11.3.1 Middle East & Africa Insulin Glargine Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Insulin Glargine Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Insulin Glargine Market Drivers
    12.2 Insulin Glargine Market Restraints
    12.3 Insulin Glargine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Insulin Glargine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Insulin Glargine
    13.3 Insulin Glargine Production Process
    13.4 Insulin Glargine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Insulin Glargine Typical Distributors
    14.3 Insulin Glargine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Insulin Glargine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Insulin Glargine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi-Aventis Major Business
    Table 5. Sanofi-Aventis Insulin Glargine Product and Services
    Table 6. Sanofi-Aventis Insulin Glargine Sales Quantity (M mL), Average Price (USD/mL), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Sanofi-Aventis Recent Developments/Updates
    Table 8. Ganlee Basic Information, Manufacturing Base and Competitors
    Table 9. Ganlee Major Business
    Table 10. Ganlee Insulin Glargine Product and Services
    Table 11. Ganlee Insulin Glargine Sales Quantity (M mL), Average Price (USD/mL), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Ganlee Recent Developments/Updates
    Table 13. Biocon Basic Information, Manufacturing Base and Competitors
    Table 14. Biocon Major Business
    Table 15. Biocon Insulin Glargine Product and Services
    Table 16. Biocon Insulin Glargine Sales Quantity (M mL), Average Price (USD/mL), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Biocon Recent Developments/Updates
    Table 18. Global Insulin Glargine Sales Quantity by Manufacturer (2019-2024) & (M mL)
    Table 19. Global Insulin Glargine Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 20. Global Insulin Glargine Average Price by Manufacturer (2019-2024) & (USD/mL)
    Table 21. Market Position of Manufacturers in Insulin Glargine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 22. Head Office and Insulin Glargine Production Site of Key Manufacturer
    Table 23. Insulin Glargine Market: Company Product Type Footprint
    Table 24. Insulin Glargine Market: Company Product Application Footprint
    Table 25. Insulin Glargine New Market Entrants and Barriers to Market Entry
    Table 26. Insulin Glargine Mergers, Acquisition, Agreements, and Collaborations
    Table 27. Global Insulin Glargine Sales Quantity by Region (2019-2024) & (M mL)
    Table 28. Global Insulin Glargine Sales Quantity by Region (2025-2030) & (M mL)
    Table 29. Global Insulin Glargine Consumption Value by Region (2019-2024) & (USD Million)
    Table 30. Global Insulin Glargine Consumption Value by Region (2025-2030) & (USD Million)
    Table 31. Global Insulin Glargine Average Price by Region (2019-2024) & (USD/mL)
    Table 32. Global Insulin Glargine Average Price by Region (2025-2030) & (USD/mL)
    Table 33. Global Insulin Glargine Sales Quantity by Type (2019-2024) & (M mL)
    Table 34. Global Insulin Glargine Sales Quantity by Type (2025-2030) & (M mL)
    Table 35. Global Insulin Glargine Consumption Value by Type (2019-2024) & (USD Million)
    Table 36. Global Insulin Glargine Consumption Value by Type (2025-2030) & (USD Million)
    Table 37. Global Insulin Glargine Average Price by Type (2019-2024) & (USD/mL)
    Table 38. Global Insulin Glargine Average Price by Type (2025-2030) & (USD/mL)
    Table 39. Global Insulin Glargine Sales Quantity by Application (2019-2024) & (M mL)
    Table 40. Global Insulin Glargine Sales Quantity by Application (2025-2030) & (M mL)
    Table 41. Global Insulin Glargine Consumption Value by Application (2019-2024) & (USD Million)
    Table 42. Global Insulin Glargine Consumption Value by Application (2025-2030) & (USD Million)
    Table 43. Global Insulin Glargine Average Price by Application (2019-2024) & (USD/mL)
    Table 44. Global Insulin Glargine Average Price by Application (2025-2030) & (USD/mL)
    Table 45. North America Insulin Glargine Sales Quantity by Type (2019-2024) & (M mL)
    Table 46. North America Insulin Glargine Sales Quantity by Type (2025-2030) & (M mL)
    Table 47. North America Insulin Glargine Sales Quantity by Application (2019-2024) & (M mL)
    Table 48. North America Insulin Glargine Sales Quantity by Application (2025-2030) & (M mL)
    Table 49. North America Insulin Glargine Sales Quantity by Country (2019-2024) & (M mL)
    Table 50. North America Insulin Glargine Sales Quantity by Country (2025-2030) & (M mL)
    Table 51. North America Insulin Glargine Consumption Value by Country (2019-2024) & (USD Million)
    Table 52. North America Insulin Glargine Consumption Value by Country (2025-2030) & (USD Million)
    Table 53. Europe Insulin Glargine Sales Quantity by Type (2019-2024) & (M mL)
    Table 54. Europe Insulin Glargine Sales Quantity by Type (2025-2030) & (M mL)
    Table 55. Europe Insulin Glargine Sales Quantity by Application (2019-2024) & (M mL)
    Table 56. Europe Insulin Glargine Sales Quantity by Application (2025-2030) & (M mL)
    Table 57. Europe Insulin Glargine Sales Quantity by Country (2019-2024) & (M mL)
    Table 58. Europe Insulin Glargine Sales Quantity by Country (2025-2030) & (M mL)
    Table 59. Europe Insulin Glargine Consumption Value by Country (2019-2024) & (USD Million)
    Table 60. Europe Insulin Glargine Consumption Value by Country (2025-2030) & (USD Million)
    Table 61. Asia-Pacific Insulin Glargine Sales Quantity by Type (2019-2024) & (M mL)
    Table 62. Asia-Pacific Insulin Glargine Sales Quantity by Type (2025-2030) & (M mL)
    Table 63. Asia-Pacific Insulin Glargine Sales Quantity by Application (2019-2024) & (M mL)
    Table 64. Asia-Pacific Insulin Glargine Sales Quantity by Application (2025-2030) & (M mL)
    Table 65. Asia-Pacific Insulin Glargine Sales Quantity by Region (2019-2024) & (M mL)
    Table 66. Asia-Pacific Insulin Glargine Sales Quantity by Region (2025-2030) & (M mL)
    Table 67. Asia-Pacific Insulin Glargine Consumption Value by Region (2019-2024) & (USD Million)
    Table 68. Asia-Pacific Insulin Glargine Consumption Value by Region (2025-2030) & (USD Million)
    Table 69. South America Insulin Glargine Sales Quantity by Type (2019-2024) & (M mL)
    Table 70. South America Insulin Glargine Sales Quantity by Type (2025-2030) & (M mL)
    Table 71. South America Insulin Glargine Sales Quantity by Application (2019-2024) & (M mL)
    Table 72. South America Insulin Glargine Sales Quantity by Application (2025-2030) & (M mL)
    Table 73. South America Insulin Glargine Sales Quantity by Country (2019-2024) & (M mL)
    Table 74. South America Insulin Glargine Sales Quantity by Country (2025-2030) & (M mL)
    Table 75. South America Insulin Glargine Consumption Value by Country (2019-2024) & (USD Million)
    Table 76. South America Insulin Glargine Consumption Value by Country (2025-2030) & (USD Million)
    Table 77. Middle East & Africa Insulin Glargine Sales Quantity by Type (2019-2024) & (M mL)
    Table 78. Middle East & Africa Insulin Glargine Sales Quantity by Type (2025-2030) & (M mL)
    Table 79. Middle East & Africa Insulin Glargine Sales Quantity by Application (2019-2024) & (M mL)
    Table 80. Middle East & Africa Insulin Glargine Sales Quantity by Application (2025-2030) & (M mL)
    Table 81. Middle East & Africa Insulin Glargine Sales Quantity by Region (2019-2024) & (M mL)
    Table 82. Middle East & Africa Insulin Glargine Sales Quantity by Region (2025-2030) & (M mL)
    Table 83. Middle East & Africa Insulin Glargine Consumption Value by Region (2019-2024) & (USD Million)
    Table 84. Middle East & Africa Insulin Glargine Consumption Value by Region (2025-2030) & (USD Million)
    Table 85. Insulin Glargine Raw Material
    Table 86. Key Manufacturers of Insulin Glargine Raw Materials
    Table 87. Insulin Glargine Typical Distributors
    Table 88. Insulin Glargine Typical Customers
List of Figures
    Figure 1. Insulin Glargine Picture
    Figure 2. Global Insulin Glargine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Insulin Glargine Consumption Value Market Share by Type in 2023
    Figure 4. Single Dose Vial Examples
    Figure 5. Pre-filled Syringe Examples
    Figure 6. Global Insulin Glargine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Insulin Glargine Consumption Value Market Share by Application in 2023
    Figure 8. Treat Type2 Diabetes Examples
    Figure 9. Treat Type1 Diabetes Examples
    Figure 10. Global Insulin Glargine Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global Insulin Glargine Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Insulin Glargine Sales Quantity (2019-2030) & (M mL)
    Figure 13. Global Insulin Glargine Average Price (2019-2030) & (USD/mL)
    Figure 14. Global Insulin Glargine Sales Quantity Market Share by Manufacturer in 2023
    Figure 15. Global Insulin Glargine Consumption Value Market Share by Manufacturer in 2023
    Figure 16. Producer Shipments of Insulin Glargine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 17. Top 3 Insulin Glargine Manufacturer (Consumption Value) Market Share in 2023
    Figure 18. Top 6 Insulin Glargine Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Global Insulin Glargine Sales Quantity Market Share by Region (2019-2030)
    Figure 20. Global Insulin Glargine Consumption Value Market Share by Region (2019-2030)
    Figure 21. North America Insulin Glargine Consumption Value (2019-2030) & (USD Million)
    Figure 22. Europe Insulin Glargine Consumption Value (2019-2030) & (USD Million)
    Figure 23. Asia-Pacific Insulin Glargine Consumption Value (2019-2030) & (USD Million)
    Figure 24. South America Insulin Glargine Consumption Value (2019-2030) & (USD Million)
    Figure 25. Middle East & Africa Insulin Glargine Consumption Value (2019-2030) & (USD Million)
    Figure 26. Global Insulin Glargine Sales Quantity Market Share by Type (2019-2030)
    Figure 27. Global Insulin Glargine Consumption Value Market Share by Type (2019-2030)
    Figure 28. Global Insulin Glargine Average Price by Type (2019-2030) & (USD/mL)
    Figure 29. Global Insulin Glargine Sales Quantity Market Share by Application (2019-2030)
    Figure 30. Global Insulin Glargine Consumption Value Market Share by Application (2019-2030)
    Figure 31. Global Insulin Glargine Average Price by Application (2019-2030) & (USD/mL)
    Figure 32. North America Insulin Glargine Sales Quantity Market Share by Type (2019-2030)
    Figure 33. North America Insulin Glargine Sales Quantity Market Share by Application (2019-2030)
    Figure 34. North America Insulin Glargine Sales Quantity Market Share by Country (2019-2030)
    Figure 35. North America Insulin Glargine Consumption Value Market Share by Country (2019-2030)
    Figure 36. United States Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 37. Canada Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Mexico Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Europe Insulin Glargine Sales Quantity Market Share by Type (2019-2030)
    Figure 40. Europe Insulin Glargine Sales Quantity Market Share by Application (2019-2030)
    Figure 41. Europe Insulin Glargine Sales Quantity Market Share by Country (2019-2030)
    Figure 42. Europe Insulin Glargine Consumption Value Market Share by Country (2019-2030)
    Figure 43. Germany Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. France Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. United Kingdom Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. Russia Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Italy Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Asia-Pacific Insulin Glargine Sales Quantity Market Share by Type (2019-2030)
    Figure 49. Asia-Pacific Insulin Glargine Sales Quantity Market Share by Application (2019-2030)
    Figure 50. Asia-Pacific Insulin Glargine Sales Quantity Market Share by Region (2019-2030)
    Figure 51. Asia-Pacific Insulin Glargine Consumption Value Market Share by Region (2019-2030)
    Figure 52. China Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Japan Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Korea Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. India Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Southeast Asia Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Australia Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. South America Insulin Glargine Sales Quantity Market Share by Type (2019-2030)
    Figure 59. South America Insulin Glargine Sales Quantity Market Share by Application (2019-2030)
    Figure 60. South America Insulin Glargine Sales Quantity Market Share by Country (2019-2030)
    Figure 61. South America Insulin Glargine Consumption Value Market Share by Country (2019-2030)
    Figure 62. Brazil Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. Argentina Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Middle East & Africa Insulin Glargine Sales Quantity Market Share by Type (2019-2030)
    Figure 65. Middle East & Africa Insulin Glargine Sales Quantity Market Share by Application (2019-2030)
    Figure 66. Middle East & Africa Insulin Glargine Sales Quantity Market Share by Region (2019-2030)
    Figure 67. Middle East & Africa Insulin Glargine Consumption Value Market Share by Region (2019-2030)
    Figure 68. Turkey Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 69. Egypt Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Saudi Arabia Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. South Africa Insulin Glargine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Insulin Glargine Market Drivers
    Figure 73. Insulin Glargine Market Restraints
    Figure 74. Insulin Glargine Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Insulin Glargine in 2023
    Figure 77. Manufacturing Process Analysis of Insulin Glargine
    Figure 78. Insulin Glargine Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Companies Mentioned

Sanofi-Aventis
Ganlee
Biocon